Yeshiva University: Reducing Blood Cancer Patients' Need for Transfusions
January 22, 2020
January 22, 2020
BRONX, New York, Jan. 22 [TNSmedicalresearch] -- Yeshiva University's Albert Einstein College of Medicine issued the following news release:
* * *
- Research at Albert Einstein College of Medicine and Montefiore Health System Contributed to Development of New Drug
* * *
A clinical trial has found the drug luspatercept significantly reduced the need for blood transfusions in people with lower-risk myelodysplastic syndromes (MDS), a group of bone . . .
* * *
- Research at Albert Einstein College of Medicine and Montefiore Health System Contributed to Development of New Drug
* * *
A clinical trial has found the drug luspatercept significantly reduced the need for blood transfusions in people with lower-risk myelodysplastic syndromes (MDS), a group of bone . . .